Topical tacrolimus in the management of atopic dermatitis in Japan

Dermatologic Therapy

Volumn 19, Issue 2, 2006, Pages 118-126

  Furue, Masutaka ^a   Uchi, Hiroshi ^a   Moroi, Yoichi ^a   Ogawa, Sachiko ^a   Nakahara, Takeshi ^a   Urabe, Kazunori ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Adverse effects; Atopic dermatitis; Dose; Topical steroids; Topical tacrolimus

Indexed keywords

ALCLOMETASONE DIPROPIONATE; BETAMETHASONE VALERATE; CALCINEURIN INHIBITOR; CORTICOSTEROID; EMOLLIENT AGENT; HYDROCORTISONE ACETATE; HYDROCORTISONE BUTYRATE; PIMECROLIMUS; STEROID; TACROLIMUS;

ACNE; ATOPIC DERMATITIS; BACTERIAL INFECTION; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTACT DERMATITIS; DERMATITIS; DERMATOMYCOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED CANCER; DRUG POTENCY; DRUG SAFETY; ECZEMA; ENDOCRINE DISEASE; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; FOLLICULITIS; FOLLOW UP; GLAUCOMA; GROWTH RETARDATION; HERPES SIMPLEX; HORMONE ACTION; HUMAN; HYPERTRICHOSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFECTION RISK; JAPAN; LONG TERM CARE; MOLLUSCUM CONTAGIOSUM; NONHUMAN; PROPHYLAXIS; PRURITUS; RECURRENT DISEASE; REVIEW; ROSACEA LIKE DERMATITIS; SKIN ATROPHY; SKIN BURNING SENSATION; SKIN INFECTION; SKIN IRRITATION; TELANGIECTASIA;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; SEVERITY OF ILLNESS INDEX; TACROLIMUS;

EID: 33645881082     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2006.00064.x     Document Type: Review

References (47)

1. Williams HC. Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol 1992 17 385 391.
2. Williams HC Robertson C Stewart A. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 1999 103 125 138.
3. Takeuchi M Ueda H. Increase of atopic dermatitis (AD) in recent Japan. Environ Dermatol 2000 7 133 136.
4. Sugiura H Umemoto N Deguchi H et al. Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago. Acta Derm Venereol 1998 78 293 294.
5. Yamamoto S. Prevalence and exacerbation factors of atopic dermatitis. Skin Allergy Frontier 2003 1 85 90 (in Japanese).
6. Charman CR Morris AD Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000 142 931 936.
7. Nakagawa H Etoh T Ishibashi Y et al. Tacrolimus ointment for atopic dermatitis. Lancet 1994 344 883.
8. Reitamo S Rustin M Ruzicka T et al. European Tacrolimus Ointment Study Group. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002 109 547 555.
9. Lazarous MC Kerdel FA. Topical tacrolimus protopic. Drugs Today 2002 38 7 15.
10. Furue M Terao H Rikihisa W et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol 2003 148 128 133.
11. Brunsting LA. Atopic dermatitis (disseminated neurodermatitis) of young adults. Arch Derm Syph 1936 34 935 957.
12. Wilson L Williams DI Marsh SD. Plasma corticosteroid levels in out-patients treated with topical steroids. Br J Dermatol 1973 88 373 380.
13. Munro DD Clift DC. Pituitary-adrenal function after prolonged use of topical corticosteroids. Br J Dermatol 1973 88 381 385.
14. Furue M Terao H Moroi Y et al. Dosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitis. J Dermatol 2004 31 277 283.
15. Japanese Dermatological Association criteria for the diagnosis of atopic dermatitis. Jap J Dermatol 1996 106 64 65.
16. David TJ Cambridge GC. Bacterial infection in atopic eczema. Arch Dis Child 1986 81 20 23.
17. David TJ Longson M. Herpes simplex infection in atopic eczema. Arch Dis Child 1985 60 338 343.
18. Fleischer AB Jr. Ling M Eichenfield L et al. Tacrolimus Ointment Study Group. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. J Am Acad Dermatol 2002 47 562 570.
19. Japanese FK-506 Ointment Study Group. Long-term study of FK-506 (tacrolimus) ointment in patients with atopic dermatitis - analysis at the time of 1-year observation. Rinsho Iyaku 1998 14 2405 2432. (in Japanese).
20. Japanese FK-506 Ointment Study Group. Late phase II study of FK-506 (tacrolimus) ointment in patients with atopic dermatitis - dose-finding study. Nishinihon J Dermatol 1997 59 427 435. (in Japanese).
21. Ishibashi Y Nakagawa H Etoh T Kawashima M Harada S. Early phase II study of FK-506 (tacrolimus) ointment in patients with atopic dermatitis. Rinsho Iyaku 1998 14 2293 2311. (in Japanese).
22. Ruzicka T Bieber T Schopf E et al. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997 337 816 821.
23. Hanifin JM Ling MR Langley R Breneman D Rafal E. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. J Am Acad Dermatol 2001 44 S28 S38.
24. Drake L Prendergast M Maher R et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001 44 S65 S72.
25. Japanese FK-506 Ointment Study Group. Phase III study of FK-506 (tacrolimus) ointment in patients with atopic dermatitis - comparison study with 0.1% alclomethasone dipropionate ointment for facial and neck lesions. Acta Dermatol (Kyoto) 1997 92 277 288. (in Japanese).
26. Reitamo S Van Leent EJ Ho V et al. European/Canadian Tacrolimus Ointment Study Group. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002 109 539 546.
27. Japanese FK-506 Ointment Study Group. Phase III study of FK-506 (tacrolimus) ointment in patients with atopic dermatitis - comparison study with 0.12% betamethasone valerate ointment for trunk and extremities lesions. Nishinihon J Dermatol 1997 59 870 879 (in Japanese).
28. Reitamo S Wollenberg A Schopf E et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000 136 999 1006.
29. Japanese FK-506 Ointment Study Group. Long-term study of FK-506 (tacrolimus) ointment in patients with atopic dermatitis - analysis at the time of completion of 2-year observation. Rinsho Iyaku 2001 17 705 726. (in Japanese).
30. Boguniewicz M Fiedler VC Raimer S Lawrence ID Leung DY Hanifin JM. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 1998 102 637 644.
31. Kang S Lucky AW Pariser D Lawrence I Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001 44 S58 S64.
32. Otsuki M Nakagawa H Kawashima M Shibata Y Harada S Japanese FK-506 ointment Study Group. Efficacy and safety of FK506 (tacrolimus) ointment in children with atopic dermatitis - phase III double-blinded comparison with vehicle ointment. Rinsho Iyaku 2003 19 569 595. (in Japanese).
33. Kawashima M Otsuki M Shibata Y Harada S Nakagawa H Japanese FK-506 ointment Study Group. Long-term study of FK506 (tacrolimus) ointment in children with atopic dermatitis. Rinsho Iyaku 2003 19 597 636. (in Japanese).
34. Otsuki M Kawashima M Harada S Nakagawa H Japanese FK-506 ointment Study Group. An extension study of FK-506 (tacrolimus) ointment as a follow-up to the double-blinded comparison study in children with atopic dermatitis. Rinsho Iyaku 2005 21 335 360.
35. Soter NA Fleischer AB Jr. Webster GF Monroe E Lawrence I. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. J Am Acad Dermatol 2001 44 S39 S46.
36. Reitamo S Rissanen J Remitz A et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998 111 396 398.
37. Ellis C Luger T Abeck D et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003 148 S3 S10.
38. Furue M Furukawa F Hide M Takehara K. Guidelines for therapy for atopic dermatitis. Jap J Dermatol 2004 114 135 142. (in Japanese).
39. Long CC Finlay AY Averill RW. The rule of hand: 4 hand areas = 2 FTU = 1 g. Arch Dermatol 1992 128 1129 1130.
40. Przybilla B Eberlein-Konig B Rueff F. Practical management of atopic eczema. Lancet 1994 343 1342 1346.
41. Sidbury R Hanifin JM. Old, new and emerging therapies for atopic dermatitis. Dermatol Clin 2000 18 1 11.
42. Raimer SS. Managing pediatric atopic dermatitis. Clin Pediatr 2000 39 1 14.
43. Williams HC. Do topical steroids reduce relapses in adults with atopic dermatitis? Arch Dermatol 1999 135 1530 1531.
44. Hanifin J Gupta AK Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol 2002 147 528 537.
45. Thomas KS Armstrong S Avery A et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. Br Med J 2002 324 768 774.
46. Nakahara T Koga T Fukagawa S Uchi H Furue M. Intermittent topical corticosteroid/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid/emollient sequential therapy in patients with atopic dermatitis. J Dermatol 2004 31 524 528.
47. Ogawa S Nakahara T Fukagawa S Kokuba H Furue M. Prior application of moisturizing camellia oil lotion decreased burning sensation of topical tacrolimus. Nishinihon J Dermatol 2005 67 56 59.